Unfortunately, experiments could not be repeated with eNK cells from NK1, NK2, NK3 and NK4 on patient samples at that moment of disease progression as the entire expanded population was spent in the experiments performed on the different B-CLL patients tested in the first assays and shown in Fig. 2. The gene discussed is IL32; the disease is B-cell chronic lymphocytic leukemia.